Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Engelhardt

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Annals of Intensive Care|October 27, 2025
Distinct diurnal temperature rhythm patterns in critical illness myopathy: secondary analysis of two prospective trialsD Mewes, S Weber-Carstens, K Rubarth, et al.
Plos One|September 10, 2016
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque ToxicologyMark J Selby, John J Engelhardt, Robert J Johnston, et al.
Plos One|November 19, 2016
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque ToxicologyMark J Selby, John J Engelhardt, Robert J Johnston, et al.
Mabs|February 22, 2022
Improved therapeutic index of an acidic pH-selective antibodyPeter S Lee, Katherine G MacDonald, Evan Massi, et al.
Toxicologic Pathology|February 24, 2018
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert WorkshopB Lenz, A Braendli-Baiocco, J Engelhardt, et al.
AJNR. American Journal of Neuroradiology|September 13, 2024
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI AnalysisA Tietze, B Bison, J Engelhardt, et al.
The Journal of Clinical Investigation|February 5, 2020
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T Freeman, Thomas R Nirschl, Daniel H Hovelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Chest|December 22, 2025
Challenges and Recommendations for Integrating Circadian Medicine in Critical Care: A RoadmapFloor W Hiemstra, Liliana Bustos González, Lilian J Engelhardt, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Annals of Intensive Care|October 27, 2025
Distinct diurnal temperature rhythm patterns in critical illness myopathy: secondary analysis of two prospective trialsD Mewes, S Weber-Carstens, K Rubarth, et al.
Plos One|September 10, 2016
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque ToxicologyMark J Selby, John J Engelhardt, Robert J Johnston, et al.
Plos One|November 19, 2016
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque ToxicologyMark J Selby, John J Engelhardt, Robert J Johnston, et al.
Mabs|February 22, 2022
Improved therapeutic index of an acidic pH-selective antibodyPeter S Lee, Katherine G MacDonald, Evan Massi, et al.
Toxicologic Pathology|February 24, 2018
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert WorkshopB Lenz, A Braendli-Baiocco, J Engelhardt, et al.
AJNR. American Journal of Neuroradiology|September 13, 2024
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI AnalysisA Tietze, B Bison, J Engelhardt, et al.
The Journal of Clinical Investigation|February 5, 2020
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T Freeman, Thomas R Nirschl, Daniel H Hovelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Chest|December 22, 2025
Challenges and Recommendations for Integrating Circadian Medicine in Critical Care: A RoadmapFloor W Hiemstra, Liliana Bustos González, Lilian J Engelhardt, et al.
Pageof 6